Michael J. Caulfield

Author

Also Known As

Caulfield, Michael J., M Caulfield, M J Caulfield, M. Caulfield, M. J. CAULFIELD, M. J. Caulfield, M.J. Caulfield, M. J. Caulfield, Michael Caulfield, Michael J Caulfield

Publications

6.6K

Citations

H-Index

Concepts

All Affiliations

United States Military Academy Cleveland Clinic Merck & Co., Inc., Rahway, NJ, USA (United States)University of Colorado Denver University of California San Diego

About

Michael J. Caulfield is an author at United States Military Academy specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	33	4.1K
2	Allergy	9	9	699
3	Engineering	3	3	109
4	Health Sciences	2	2	213
5	Biochemistry	1	1	42

Michael J. Caulfield

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity John W. Shiver, Tong‐Ming Fu, Ling Chen, Nature VaccinationHuman RetrovirusImmunologyAntiviral ResponseVirology	2002	1.2K
Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 <i>gag</i> Gene Danilo R. Casimiro, Ling Chen, Tong‐Ming Fu, Journal of Virology	2003	396
Varicella‐Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine Myron J. Levin, Michael N. Oxman, J. H. Zhang, The Journal of Infectious Diseases	2008	346
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120 Leopold Kong, Jeong Hyun Lee, Katie J. Doores, Nature Structural & Molecular Biology	2013	342
Decline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV Vaccine Myron J. Levin, Jeffrey G. Smith, Robin M. Kaufhold, The Journal of Infectious Diseases Healthy SubjectsImmunologyIncreasing AgeHigh‐dose Vzv VaccineImmunotherapy	2003	316
Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes Tong‐Ming Fu, Jeffrey B. Ulmer, Michael J. Caulfield, Molecular Medicine VaccinationCytotoxic T LymphocytesAllergyImmunologyImmunodominance	1997	295
Varicella‐Zoster Virus–Specific Immune Responses to Herpes Zoster in Elderly Participants in a Trial of a Clinically Effective Zoster Vaccine Adriana Weinberg, Jane H. Zhang, Michael N. Oxman, The Journal of Infectious Diseases	2009	268
A Novel <i>Staphylococcus aureus</i> Vaccine: Iron Surface Determinant B Induces Rapid Antibody Responses in Rhesus Macaques and Specific Increased Survival in a Murine <i>S. aureus</i> Sepsis Model Nelly A. Kuklin, Desmond Clark, Susan Secore, Infection and Immunity Humoral ResponseImmunologyStaphylococcus AureusS. Aureus DiseaseImmune System	2006	257
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9 Jean‐Philippe Julien, Jeong Hyun Lee, Albert Cupo, Proceedings of the National Academy of Sciences	2013	241
Protective CD4<sup>+</sup>and CD8<sup>+</sup>T Cells against Influenza Virus Induced by Vaccination with Nucleoprotein DNA Jeffrey B. Ulmer, Tong‐Ming Fu, R. Randall Deck, Journal of Virology Nucleoprotein DnaImmunologyCd4 T Cell ResponsesImmune SystemImmunotherapy	1998	230

Page 1